Tag
#SF
-
2026
-
Stifel Financial Schedules Second Quarter Financial Results Conference Call
-
ERRINGTON METALS CORP. ANNOUNCES UPSIZE OF PRIVATE PLACEMENT TO $30 MILLION
-
Stifel Tops JD Power Study for Fourth Straight Year
-
AI Adoption Accelerates, Driving Financial Advisor Loyalty, JD Power Finds
-
Sage Crosses $100 Million in 2026 Funding with $35 Million Debt Facility from Stifel Bank
-
Stifel Reports May 2026 Operating Data
-
SF – 8-K
-
SF – 8-K
-
ATS to Participate in the Stifel Summer Solstice Conference
-
BerryDunn’s 15th Annual Banking Summit Delivered Critical Industry Updates
-
Limbach to Participate in Stifel’s Ninth Annual Boston Cross Sector 1×1 Conference
-
Stifel Reports April 2026 Operating Data
-
SF – 8-K
-
SF – DEFA14A
-
Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum
-
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day
-
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
-
Cloudbreak Pharma to Present at the Stifel 2026 Virtual Ophthalmology Forum
-
AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum
-
Stifel Launches Project Finance Offering to Expand Energy and Deep Tech Capabilities
-
SF – 10-Q
-
Stifel Declares Quarterly Common Stock Cash Dividend and Declares Preferred Stock Cash Dividend
-
SF – DEF 14A
-
SF – DEFA14A
-
Stifel Reports First Quarter 2026 Results